Press releases
- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
More ▼
Key statistics
On Monday, Haemonetics Corp (HAZ:STU) closed at 76.50, 17.69% above the 52 week low of 65.00 set on Feb 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 76.50 |
---|---|
High | 76.50 |
Low | 76.50 |
Bid | 76.50 |
Offer | 79.00 |
Previous close | 76.50 |
Average volume | 6.67 |
---|---|
Shares outstanding | 50.84m |
Free float | 50.45m |
P/E (TTM) | 36.76 |
Market cap | 4.27bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of Jun 03 2024.
More ▼